医療用医薬品の適正な流通の確保の徹底について ｜報道発表資料｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000151892.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. The first export request adds an external RFC 3161 timestamp before download.
医療用医薬品の適正な流通の確保の徹底について ｜報道発表資料｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page is a press release from Japan's Ministry of Health, Labour and Welfare dated February 16, 2017. Following the discovery of counterfeit C-type hepatitis treatment drug "Harvoni Combination Tablets," the ministry announces measures to ensure proper distribution of pharmaceutical products for medical use. The ministry issues alerts to wholesalers and pharmacies and strengthens supervisory guidance. Contact information for relevant departments is provided.
